Skip to main
OFIX
OFIX logo

Orthofix International (OFIX) Stock Forecast & Price Target

Orthofix International (OFIX) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Orthofix Medical Inc. is anticipated to achieve robust top-line growth, with expectations for the global orthopedics business to show sustainable growth of at least mid-to-upper single digits, driven by distribution expansion and deeper account penetration. The company’s adjusted EBITDA margin is projected to increase significantly from 8.4% in 2024 to 13.5% by 2027, indicating a positive trajectory in profitability. Additionally, the shift towards positive and growing free cash generation starting in the second half of 2025 further enhances the company's financial outlook, suggesting strong operational performance in the coming years.

Bears say

Orthofix Medical Inc. faces a challenging financial outlook characterized by an anticipated net interest expense ranging from $19 million to $20 million for fiscal year 2025, potentially limiting profitability and impacting free cash flow generation in the subsequent years. The company's adjusted EBITDA margins in its orthopedics segment are notably low at 3.7% for fiscal year 2024, exacerbated by SG&A expenses that significantly exceed projections, suggesting ongoing operational inefficiencies. Additionally, despite positive growth trends within the spine and orthopedic markets, the company's innovation and product development have lagged, leading to a valuation that remains just above 52-week lows and a disappointing growth rate following earlier projections.

Orthofix International (OFIX) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Orthofix International and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Orthofix International (OFIX) Forecast

Analysts have given Orthofix International (OFIX) a Strong Buy based on their latest research and market trends.

According to 4 analysts, Orthofix International (OFIX) has a Strong Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Orthofix International (OFIX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.